ArticleFrontiers in immunology2025

IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse model.

Gavin Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.